Lilly Continues Foray into Gene Therapies with $487M Akouos Buyout 0 18.10.2022 03:00 Feedity.com Eli Lilly is acquiring precision medicine biotech Akouos for $487 million in cash in a deal focused on developing gene therapies for hearing loss. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
